ACA
SBIO icon

Atlas Capital Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Atlas Capital Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,400
Closed -$70.4K – 958
2021
Q1 		$70.4K Buy
+1,400
New +$77.5K 0.01% 462

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Atlas Capital Advisors's SBIO Position: Q2 2021 in Review

Atlas Capital Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2021, closing a stake of 1,400 shares — an estimated $70.4K sold.

Atlas Capital Advisors first reported a position in SBIO in Q1 2021 and held it in 1 quarter. The position peaked at $70.4K in Q1 2021. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2021.

  • Atlas Capital Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2021 after selling out during the quarter.
  • Atlas Capital Advisors sold 1,400 ALPS Medical Breakthroughs ETF shares in Q2 2021, an estimated $70.4K.
  • Atlas Capital Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q1 2021 and held it in 1 quarter.
  • Atlas Capital Advisors's ALPS Medical Breakthroughs ETF position peaked at $70.4K in Q1 2021.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2021.

Based on Atlas Capital Advisors's 13F filing for Q2 2021, filed 30 Jul 2021.